| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 29.903 | 668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 29.903 | 668 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Expenses - EUR | 27.496 | 8.674 | 204 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit/Loss - EUR | 2.407 | -8.006 | -204 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit/Loss - EUR | 1.510 | -8.026 | -204 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Employees | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ipeca Intermed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 29.021 | 17.935 | 17.421 | 17.101 | 3.020 | 2.963 | 2.897 | 2.906 | 2.843 | 2.827 |
| Inventories | 3.611 | 3.574 | 3.513 | 3.449 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 0 | 74 | 59 | 58 | 56 | 55 | 54 | 54 | 0 | 0 |
| Cash | 25.411 | 14.286 | 13.849 | 13.594 | 2.963 | 2.907 | 2.843 | 2.851 | 2.843 | 2.827 |
| Shareholders Funds | 26.221 | 17.928 | 17.421 | 17.101 | 3.020 | 2.963 | 2.897 | 2.906 | 2.843 | 2.827 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.800 | 7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Ipeca Intermed Srl